Q3 EPS Estimates for Aurora Cannabis Decreased by Analyst

Aurora Cannabis Inc. (NASDAQ:ACB) – Equities researchers at Atb Cap Markets cut their Q3 2025 earnings per share (EPS) estimates for Aurora Cannabis in a report issued on Monday, December 16th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their previous forecast of ($0.09). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.02) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.10) EPS, FY2025 earnings at ($0.10) EPS, FY2026 earnings at ($0.16) EPS, FY2027 earnings at ($0.01) EPS and FY2029 earnings at $0.40 EPS.

Several other research analysts have also recently weighed in on ACB. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. TD Cowen began coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They set a “buy” rating for the company.

Aurora Cannabis Price Performance

ACB opened at $4.10 on Thursday. The company’s 50-day simple moving average is $4.91 and its two-hundred day simple moving average is $5.48. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83. The stock has a market capitalization of $224.86 million, a P/E ratio of -5.39 and a beta of 1.86. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35.

Institutional Investors Weigh In On Aurora Cannabis

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Cubist Systematic Strategies LLC purchased a new stake in shares of Aurora Cannabis in the 2nd quarter worth $50,000. Toronto Dominion Bank raised its holdings in Aurora Cannabis by 34,356.4% in the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after purchasing an additional 18,896 shares during the period. Mackenzie Financial Corp purchased a new position in Aurora Cannabis during the second quarter valued at $113,000. TD Asset Management Inc bought a new stake in Aurora Cannabis during the second quarter valued at about $255,000. Finally, Headlands Technologies LLC raised its stake in shares of Aurora Cannabis by 98.8% in the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock worth $346,000 after buying an additional 37,269 shares during the period. Hedge funds and other institutional investors own 47.63% of the company’s stock.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.